<?xml version="1.0" encoding="UTF-8"?>
<p>To examine the modulatory influence of pretreatment of RAP (100 and 200 mg/kg) on the inflammatory cytokines and markers (TNF-α, IL-1β, IL-6, and VEGF) levels were determined. LPS administration increases the influx of pro-inflammatory cytokines. As shown in 
 <xref ref-type="fig" rid="molecules-25-06045-f004">Figure 4</xref>, LPS treatment prompted a significant (
 <italic>p</italic> &lt; 0.05) increase in TNF-α level (215.02 ± 12.14 from 31.22 ± 3.70 to pg/mL), IL-1β level (772.03 ± 45.52 from 78.19 ± 5.16 pg/mL, 
 <italic>p</italic> &lt; 0.05), and IL-6 level (1164.30 ±51.92 from 319.39 ± 16.19 pg/mL) when compared with normal control rats.
</p>
